Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0N0ME
|
|||
Former ID |
DNC010620
|
|||
Drug Name |
4-benzhydryl-N-butylpiperazine-1-carboxamide
|
|||
Synonyms |
4-benzhydryl-N-butylpiperazine-1-carboxamide; CHEMBL1087032; 681801-59-2; N-butyl-4-(diphenylmethyl)piperazine-1-carboxamide; (4-(DIPHENYLMETHYL)PIPERAZINYL)-N-BUTYLFORMAMIDE; AC1MDDX7; AC1Q2X1X; MLS001181725; MolPort-001-841-442; HMS2858M18; HMS1662P18; KS-000029IQ; BDBM50312580; ZINC19924797; AKOS022169771; MS-8361; MCULE-5902192289
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C22H29N3O
|
|||
Canonical SMILES |
CCCCNC(=O)N1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
|
|||
InChI |
1S/C22H29N3O/c1-2-3-14-23-22(26)25-17-15-24(16-18-25)21(19-10-6-4-7-11-19)20-12-8-5-9-13-20/h4-13,21H,2-3,14-18H2,1H3,(H,23,26)
|
|||
InChIKey |
QRGYLEAVFDZUPV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Cannabinoid receptor 1 (CB1) | Target Info | Inhibitor | [1] |
Cannabinoid receptor 2 (CB2) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
Rap1 signaling pathway | ||||
Retrograde endocannabinoid signaling | ||||
Panther Pathway | Endogenous cannabinoid signaling | |||
Pathway Interaction Database | N-cadherin signaling events | |||
Reactome | Class A/1 (Rhodopsin-like receptors) | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling | ||||
BDNF signaling pathway | ||||
GPCRs, Other |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach. Eur J Med Chem. 2010 Mar;45(3):1133-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.